Glycoconjugate vaccines based on the Vi capsular polysaccharide directed against Salmonella enterica serovar Typhi are licensed or in development against typhoid fever, an important cause of morbidity and mortality in developing countries. Quantification of free polysaccharide in conjugate vaccines is an important quality control for release, to monitor vaccine stability and to ensure appropriate immune response. However, we found that existing separation methods based on size are not appropriate as free Vi non-specifically binds to unconjugated and conjugated protein. We developed a method based on free Vi separation by Capto Adhere resin and quantification by HPAEC-PAD. The method has been tested for conjugates of Vi derived from Citrobacter freundii with different carrier proteins such as CRM 197 , Tetanus Toxoid and Diphtheria Toxoid.
Introduction
Typhoid fever remains a major public health concern in lowincome countries and affects millions of people each year [1] . Antibodies directed against the Vi antigen, which forms a polysaccharide capsule around Salmonella enterica serovar Typhi (S. Typhi), mediate protection and Vi polysaccharide vaccines are currently licensed against typhoid fever [2] . Being a T-independent antigen, the Vi is not immunogenic in infants and Vi polysaccharide vaccines are only licensed for children over two years of age. Recent years have seen major efforts to develop glycoconjugate vaccines against S. Typhi [3] with Vi covalently linked to an appropriate carrier protein as a source of T-cell epitopes.
Vaccines require a comprehensive analytical characterization with a panel of quality control tests able to guarantee consistent manufacturing and immunogenicity. Characterization of glycoconjugate vaccines is a complex procedure that involves tests on starting materials such as purified polysaccharide and carrier protein, the derivatized intermediates prior to conjugation and the final purified glycoconjugate. In particular, analytical techniques are needed for measuring the amount of free polysaccharide present in the conjugate at release and to assess changes over time as part of the stability studies. With the aim to put in place a complete panel of analytical methods for Vi-CRM 197 conjugate characterization [4] [5] [6] [7] , the development of a novel method for free Vi quantification was needed. The presence of free polysaccharide can have detrimental effects on the immunogenicity of glycoconjugate vaccines [8, 9] . Although free Vi did not negatively impact the immunogenicity of Vi-CRM 197 and Vi-diphtheria toxoid (Vi-DT) conjugate vaccines in mice [10, 11] , how these findings translate in humans is not known and quantification of free Vi is recommended for typhoid conjugate vaccines by WHO Guidelines [12] . Vi is a linear homopolymer of ␣-1,4-N-acetylgalactosaminouronic acid, almost 100% O-acetylated at the C-3 position. Size exclusion chromatography and double-immunodiffusion have been reported for free Vi determination [13] . Although size exclusion chromatography had sufficient theoretical resolution [4, 14] , it was found that Vi can non-specifically bind to both the protein and the conjugate itself [5] affecting the separation. This was especially problematic when low amounts of unconjugated Vi need to be quantified as residual impurities in purified conjuates.
Methods commonly used for free polysaccharide separation in conjugate vaccines, such as ammonium sulphate/ethanol/CTAB/deoxycholate conjugate precipitation [15] , capillary electrophoresis [16, 17] , ultrafiltration [18] , reverse phase-solid phase extraction separation (3M Empore SPE C18, Phenomenex Strata XL Polymeric Reversed Phase SPE and Grace Vydac C4 SPE) [19] , ion exchange chromatography, hydrophobic interaction chromatography and affinity chromatography with anti-DT antibodies failed to adequately quantify the amount of free Vi when tried in our lab (data not shown). In these experiments, ion exchange chromatography, hydrophobic interaction chromatography and affinity chromatography resins mainly act as size exclusion media with Vi and Vi-CRM 197 eluting at the void volume of the columns and having no or limited interaction with the resin binding sites.
Here, we describe a novel reproducible method for free Vi quantification in conjugate vaccines based on polysaccharide separation by Capto Adhere resin and the subsequent quantification by high performance anion exchange chromatography with pulsed amperometric detection (HPAEC-PAD). The method was developed for Vi-CRM 197 and then verified with Vi conjugates of other carrier proteins.
Material and methods

Chemicals and antigens
The following chemicals were used in this study: sodium chloride (NaCl), monobasic sodium phosphate (NaH 2 PO 4 ), sodium acetate (NaOAc), Tween 20, bovine serum albumin (BSA) [Sigma Aldrich]; acetonitrile (ACN) [LC-MS Chromasolv]; phosphate buffer solution (PBS) [Medicago] . Vi polysaccharide (molecular weight 245 kDa on TSK gel 6000-5000 columns with Polyethylene oxide standards) was purified from Citrobacter freundii as previously described [5] . Vi-CRM 197 , Vi-TT and Vi-DT conjugates were synthesized with slightly modifications to the method described in [5] . Briefly, Vi was solubilized in 100 mM MES (2-(N-morpholino)ethane sulfonic acid) pH 6 at a concentration of 4.2 mg/mL. NHS (N-hydroxysuccinimide) and then EDAC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide) were added to have NHS concentration of 0.33 M and EDAC to Vi repeating units molar ratio of 5 to 1. After the reaction was mixed at room temperature for 1 h, the protein, previously derivatised with ADH linker, was added to give Vi and protein concentration each in the range 1.7-3.5 mg/mL (weight ratio equal to 1).
High pressure liquid chromatography -size exclusion chromatography (HPLC-SEC)
All samples were eluted on a TSK gel 6000 PW (30 cm × 7.5 mm) column (particle size 17 m; Sigma 8-05765) connected in series with a TSK gel 5000 PW (30 cm × 7.5 mm) column (particle size 17 m; Sigma 8-05764) with TSK gel PWH guard column (7.5 mm ID × 7.5 cm L; particle size 13 m; Sigma 8-06732) (Tosoh Bioscience). The mobile phase was 0.1 M NaCl, 0.1 M NaH 2 PO 4 , pH 7.2 containing 5 or 30% ACN, at the flow rate of 0.5 mL/min (isocratic method for 60 min), 80 L injection volume. Void and bed volume calibration was performed with -DNA (-DNA Molecular Weight Marker III 0.12-21.2 Kbp, Roche) and sodium azide (NaN 3 , Merck), respectively. Unconjugated Vi peaks were detected by differential refractive index (dRI) and by UV detection at 214 nm. UV detection at 214 nm and 280 nm was used for conjugate detection together with fluorescence (with emission and excitation wavelength at 336 nm and 280 nm, respectively).
Free Vi content determination by Capto Adhere -HPAEC-PAD
The pellet derived from a low speed centrifugation of 500 L of Capto Adhere resin suspension, corresponding to about 50 g of vacuum dried resin, was washed twice with 20 mM NaOAc 30% ACN pH 5. The glycoconjugate sample (a maximum total Vi load equal to 150 g), in 20 mM NaH 2 PO 4 pH 7.2 and with 30% ACN, was added to the resin and incubated at room temperature for 30 min on a rotating wheel. After centrifugation, the supernatant (indicated as "unbound solution") was removed and the resin was washed twice with 1 mL 20 mM NaOAc 30% ACN pH 5 ("wash solution"). Unconjugated Vi was stripped by vortexing the resin for few seconds in 500 L of 1 M NaOAc 30% ACN pH 5. This was repeated 5 times and the supernatants ("strip solution") were pooled together.
For each step described, resin and supernatant were separated by centrifugation (5 min at 4 • C 14000 rpm). 2.5 mL of the strip solution was desalted by PD10 disposable column (GE Healthcare Life Sciences), dried under reduced pressure (SpeedVac) and reconstituted in 0.65 mL water. Such solution and the starting conjugate were assayed for Vi content by HPAEC-PAD [4] , using a Vi calibration curve with range of 16-200 g/mL. The ratio of Vi content in the strip solution (unconjugated Vi) and in the starting sample (total Vi), corrected for dilution, represents the proportion of free Vi in the sample. Same procedure was applied in parallel to the sample spiked with a known amount of free Vi (20% with respect to total Vi content in the conjugate in analysis) in order to check the recovery of polysaccharide in the whole procedure.
Dot blot
The membrane (Nitro cellulose BioRad, Trans Blot cod. 162-0112) was loaded with 150 L of samples per well, applying vacuum to the BioDot apparatus (BioRad, cod. 170-6545). After deposition, the membrane was incubated for 10 min with PBS with 0.05% Tween 20 (PBS-Tween) and 3% BSA, washed for 5 min with PBS-Tween, then incubated with diphtheria antitoxin primary antibody (NIBSC 63/008; 1: 30000 dilution in PBS-Tween) for 1 h. After washing for 5 min with PBS-Tween, the membrane was incubated for 1 h with rabbit anti-horse IgG-peroxidase (Sigma cod. A9292; 1: 10000 dilution in PBS-Tween). The membrane was then washed for 5 min with PBS-Tween and developed with Opti-4CN Kit (BioRad, cod. 170-8235) to reveal CRM 197 presence. All the incubation and washing steps were performed under moderate orbital oscillation.
Results and discussion
Attempts to quantity free Vi content by HPLC-SEC
By working on the development of a method for characterization by HPLC-SEC of Vi from different sources (e.g. S. Typhi and Citrobacter freundii), we found that, depending on the strain of origin, a maximum of 30% (for Vi from Citrobacter freundii, while lower recoveries were obtained for S. Typhi Vi) of the polysaccharide amount injected could be recovered by running the samples on TSK gel 6000-5000 PW columns in series, eluting with 0.1 M NaCl, 0.1 M NaH 2 PO 4 , pH 7.2 containing 5% ACN. Different elution buffers were then tested and a total recovery of the polysaccharide was achieved by increasing ACN concentration to 30% (Fig. 1A) . In these conditions, Vi-CRM 197 conjugate completely bound to the stationary phase of the columns made-up of polymethacrylate containing aliphatic hydroxylated groups (Fig. 1B) , as also verified by spiking the conjugate with a known amount of free Vi (Fig. 1C) .
Initially, we used these observations to develop a method to quantify free Vi in conjugate samples by HPLC-SEC, eluting with 0.1 M NaCl, 0.1 M NaH 2 PO 4 , pH 7.2 containing 30% ACN, to detect only unconjugated Vi by comparison with a Vi polysaccharide calibration curve. In these conditions, the lower quantification limit for Vi is 5 g by refractive index or 1 g by absorption at 214 nm. However, the ideal choice for free Vi quantification would not be UV detection as the extinction coefficient () of Vi varies with its O-acetylation level and possible residual modifications due to the derivatization process needed for conjugation (e.g. N-acyl isourea groups introduced by carbodiimide chemistry [20] ). This also complicates the choice of a polysaccharide standard for building the calibration curve. Furthermore an adequate cleaning procedure of the stationary phase of the column, for example with 0.1 M NaOH, needs to be implemented to remove Vi-CRM 197 because the conjugate, once bound, cannot be removed by reducing the % of ACN. We found that no more than 40 g of conjugated protein can be loaded on the columns after repeated runs of 100 L injections or after a single injection at higher volume, as a maximum amount of conjugate can be retained by the columns prior to stripping the column with 0.1 M NaOH.
Free Vi quantification by Capto Adhere resin separation/HPAEC-PAD
To develop a more sensitive assay, we hypothesized that other resins containing aliphatic hydroxylated residues, as present in the TSK gel PW columns, may be better suited. With this aim, we screened other alkyl hydroxylated resins and identified Capto Adhere (GE Healthcare Life Sciences), that has not only alkylhydroxyl groups, but also quaternary ammonium residues, as optimal.
Working with 30% ACN buffer with low salt concentration, the presence of quaternary ammonium residues allows binding both of the conjugated and the unconjugated polyanionic Vi. By incrementing the ionic strength of the buffer to 1 M salt concentration and maintaining the ACN concentration at 30%, the interaction between carboxylic groups of Vi and quaternary ammonium residues on the resin is lost, while Vi-CRM 197 remains bound to the matrix due to the interaction of the protein with alkyl-hydroxyl groups of the resin. This allowed the separation of unconjugated Vi and its subsequent quantification. The absence of conjugate in strip solutions was verified by dot-blot (Fig. 2) and HPLC-SEC chromatograms in fluorescence emission (data not shown).
This method has the advantage that large volumes of conjugate, and at low concentration, can be loaded on the resin, increasing the detection limit for free Vi. By loading 150 g of total Vi conjugate on 0.5 mL of resin, the method allows quantification of as little as 7% free Vi.
In each analysis we performed, the conjugate was spiked with a known amount of Vi polysaccharide, and a recovery of free Vi in the range of 75-120% was obtained, confirming that no signif- icant Vi amount was lost in unbound and wash solutions. Spike recovery was also within the same range using Vi derivatized with carbodiimide but not conjugated with CRM 197 , to verify that modifications on the unconjugated Vi due to the conjugation process itself did not impact on the robustness of the method. Reproducibility of the method was verified by analyzing conjugate lots repeating the whole procedure in triplicate and a CV < 7% was found. The spike recovery was in the range 75-120% for all the lots analysed, showing accuracy of the method (Table 1 ).
Verification of Capto Adhere resin separation/HPAEC-PAD assay
The method was also applied to the quantification of free Vi in conjugate lots prepared with two different carrier proteins, DT and tetanus toxoid (TT), commonly used in glycoconjugate vaccines and in the development of Vi conjugates [3] . The method also worked well irrespective of the carrier protein: no conjugate was detected in the wash or strip solutions (no peak detected in fluorescence emission by HPLC-SEC analysis) and the recoveries of the spike were in the range 75-120% (Table 1) . Precision and estimates of accuracy were comparable with values obtained with Vi-CRM 197 .
Conclusions
The immunologic benefit of conjugating T-independent polysaccharides to protein has been well documented [21] . The carrier protein provides a source of T-cell epitopes resulting in immunological memory, affinity maturation and isotype switching. In the presence of unconjugated polysaccharide the benefits afforded by conjugation can be blunted [22, 23] . As a result, regulatory guidelines require that an acceptable limit value of free polysaccharide has to be established for conjugate vaccines.
The Capto Adhere/HPAEC-PAD method now enables a reliable and quantitative measure of free Vi in Vi-conjugate vaccines.
Unexpectedly, because of the non-covalent association of Vi with conjugate, separation methods based on size can give substantial underestimate of the concentration of free Vi [5] . Our method is specific, accurate, reproducible and allows Vi quantification also in diluted samples. The method allows determination of as little as 7% free Vi and it has been tested in samples with Vi concentration down to 40 g/mL. The method has been applied to conjugates of Vi from Citrobacter freundii, and can be extended to Vi from S. Typhi considering they have identical structure. Furthermore, it has been used to assess conjugates prepared with varying Vi size (down to average of 40 kDa). This method provides a needed quality control for vaccine release, to verify consistency of production and to assess product stability over time. Such method can be easily implemented in quality control laboratories. Further work is needed for the application of this method on formulated Vi conjugate vaccines, also assessing possible interference of excipients. 
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